The economic burden of prostate cancer-Reference-Cited by-同舟云学术

The economic burden of prostate cancer

Published:2011-08-25 Issue:6 Volume:108 Page:806-813
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Roehrborn Claus G.,Black Libby K.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2011.10365.x/fullpdf

Reference34 articles.

1. Garcia M Jemal A Ward EM et al Global Cancer Facts & Figures 2007 http://www.cancer.org/Research/CancerFactsFigures/GlobalCancerFactsFigures/global-cancer-facts-figures-2007

2. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

3. The ageing male: demographics and challenges;Lunenfeld;World J Urol,2002

4. Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors;Helgesen;J Natl Cancer Inst,1996

5. A midpoint assessment of the American Cancer Society challenge goal to decrease cancer incidence by 25% between 1992 and 2015;Sedjo;CA Cancer J Clin,2007

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate high dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy: A 9-year update;Radiotherapy and Oncology;2024-09

2. A cost-benefit analysis of mass prostate cancer screening;Cost Effectiveness and Resource Allocation;2024-05-05

3. Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in Europe;European Urology;2024-05

4. Prostate cancer perspective: Africa versus the world;South African Medical Journal;2024-04-18

5. Primary cancer prevention for cancers with no known infectious etiology: Time for a new paradigm;Vaccine;2024-03